Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugs.
Klok
R M
RM
Brouwers
J R B J
JR
Van den Berg
P B
PB
De Jong-Van den Berg
L T W
LT
Tolley
K
K
Postma
M J
MJ
D000658:Amoxicillin / Q000191:economics / Q000627:therapeutic use; D017291:Clarithromycin / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D016208:Databases, Factual; D005765:Gastrointestinal Agents / Q000191:economics / Q000627:therapeutic use*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D009426:Netherlands; D054328:Proton Pump Inhibitors
D005765:Gastrointestinal Agents; D054328:Proton Pump Inhibitors; D000658:Amoxicillin; D017291:Clarithromycin